Molecular-Genetic Mechanisms for Early-Onset Obesity

早发性肥胖的分子遗传学机制

• 批准号: 6820274
• 负责人: EVGENY I ROGAEV
• 金额: $ 15.58万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-30 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6820274
• 关键词: bioenergetics; biological signal transduction; clinical research; disease /disorder onset; family genetics; gene environment interaction; gene mutation; genetic markers; genetic susceptibility; human subject; linkage mapping; metabolism disorder; molecular cloning; molecular pathology; nutrient intake activity; obesity; overeating; phenotype

DESCRIPTION (provided by applicant): Obesity in humans has reached epidemic proportions and is associated with numerous health risks, including cardiovascular disease, diabetes mellitus, certain types of cancer, and reproductive defects. Abnormal weight regulation is also linked to abnormal eating behaviors (bulimia nervosa and binge eating disorder, anorexia nervosa) and common psychiatric diseases. To elucidate the molecular mechanisms underlying extreme obesity and related phenotypes, we will study unique large families with a very early-onset form of obesity, associated with hyperphagia and metabolic dysfunction. We have recently described seven generation pedigrees with extremely obese children and adults in human genetic isolates. We plan to identify genes underlying obesity and to elucidate the molecular pathway leading to both physiological and behavioral pathogenesis in food intake. The specific aims are as follows: 1) the chromosomal locus and mutant genes will be isolated for monogenic severe obesity in families found in the genetic isolate; 2) pathogenic features of abnormal protein and downstream elements of the cascade pathway leading to excessive fat accumulation will be identified; 3) the interaction of these elements with other signal transduction systems underlying reproductive and metabolic pathogenesis will be elucidated. Positional cloning and mutation analysis will be used to accomplish these goals. Tissue samples from affected homozygous individuals and asymptomatic relatives will be collected to investigate the biological effect of the mutant gene and protein. The mechanisms of resistance to leptin receptor mediated signaling in the obese individuals will be elucidated by analysis of gene expression, and in vitro assays for intracellular signaling in a mammalian cell model. Because obesity is a frequent disorder with high risk of morbidity and mortality, identification of candidate genes and their products will help elucidate control mechanisms of food intake and body mass, and make possible the development of diagnostic markers and specific pharmacological interventions.

描述(申请人提供)：肥胖症在人类中已经达到流行的程度，并与许多健康风险有关，包括心血管疾病、糖尿病、某些类型的癌症和生殖缺陷。体重调节异常也与异常饮食行为(神经性暴食症和暴饮暴食障碍、神经性厌食症)和常见的精神疾病有关。为了阐明极端肥胖的分子机制和相关表型，我们将研究具有极早发病形式的肥胖症的独特大家庭，这些肥胖症与过度吞噬和代谢障碍相关。我们最近描述了人类基因分离中的七代极度肥胖的儿童和成年人的家系。我们计划识别导致肥胖的基因，并阐明导致食物摄入中生理和行为发病的分子途径。其具体目标如下：1)分离在基因分离中发现的单基因重度肥胖家系的染色体基因和突变基因；2)鉴定异常蛋白和导致脂肪过度堆积的级联通路下游元件的致病特征；3)阐明这些元件与其他生殖和代谢发病机制的信号转导系统的相互作用。将使用位置克隆和突变分析来实现这些目标。将收集受影响的纯合子个体和无症状亲属的组织样本，以研究突变基因和蛋白的生物学效应。肥胖个体对瘦素受体介导的信号传导的抵抗机制将通过基因表达分析和哺乳动物细胞模型的体外细胞内信号传递分析来阐明。由于肥胖是一种常见的疾病，具有高发病率和高死亡率，识别候选基因及其产物将有助于阐明食物摄入量和体重的控制机制，并使开发诊断标记和特定的药物干预成为可能。